44 related articles for article (PubMed ID: 16507320)
1. Role of epigenetics in chronic myeloid leukemia.
Machova Polakova K; Koblihova J; Stopka T
Curr Hematol Malig Rep; 2013 Mar; 8(1):28-36. PubMed ID: 23296408
[TBL] [Abstract][Full Text] [Related]
2. Extracellular matrix protein 1 (ECM1) is a potential biomarker in B cell acute lymphoblastic leukemia.
Wu LX; Zhao MY; Yan N; Zhou YL; Cao LM; Qin YZ; Jiang Q; Xu LP; Zhang XH; Huang XJ; Jiang H; Ruan GR
Clin Exp Med; 2024 Mar; 24(1):56. PubMed ID: 38546916
[TBL] [Abstract][Full Text] [Related]
3. CSRP2 transcript levels after consolidation therapy increase prognostic prediction ability in B-cell acute lymphoblastic leukaemia.
Cao LM; Zhou YL; Gale RP; Qin YZ; Wu LX; Zhao MY; Zhao XS; Chen YH; Wang Y; Jiang H; Jiang Q; Chang YJ; Liu YR; Xu LP; Zhang XH; Huang XJ; Ruan GR
Biomol Biomed; 2023 Nov; 23(6):1079-1088. PubMed ID: 37183704
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of GNA15 Inhibits Cell Proliferation
Li M; Liu Y; Liu Y; Yang L; Xu Y; Wang W; Jiang Z; Liu Y; Wang S; Wang C
Front Oncol; 2021; 11():724435. PubMed ID: 34552875
[TBL] [Abstract][Full Text] [Related]
5. Club cell-specific role of programmed cell death 5 in pulmonary fibrosis.
Park SY; Hong JY; Lee SY; Lee SH; Kim MJ; Kim SY; Kim KW; Shim HS; Park MS; Lee CG; Elias JA; Sohn MH; Yoon HG
Nat Commun; 2021 May; 12(1):2923. PubMed ID: 34011956
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of CSRP2 Promotes Leukemia Cell Proliferation and Correlates with Relapse in Adults with Acute Myeloid Leukemia.
Wang S; Zhang Y; Liu Y; Zheng R; Wu Z; Fan Y; Li M; Li M; Li T; Li Y; Jiang Z; Wang C; Liu Y
Onco Targets Ther; 2020; 13():12549-12560. PubMed ID: 33324073
[TBL] [Abstract][Full Text] [Related]
7. Synergistic antitumoral efficacy of a novel replicative adenovirus SG611-PDCD5 and daunorubicin in human leukemic cells.
Zhou YL; Yao QM; Zhou J; Chang Y; Li JL; Wang YZ; Wu HP; Chen YH; Liu YR; Huang XJ; Ruan GR
Onco Targets Ther; 2018; 11():5121-5132. PubMed ID: 30197523
[TBL] [Abstract][Full Text] [Related]
8. Cysteine and glycine-rich protein 2 (CSRP2) transcript levels correlate with leukemia relapse and leukemia-free survival in adults with B-cell acute lymphoblastic leukemia and normal cytogenetics.
Wang SJ; Wang PZ; Gale RP; Qin YZ; Liu YR; Lai YY; Jiang H; Jiang Q; Zhang XH; Jiang B; Xu LP; Huang XJ; Liu KY; Ruan GR
Oncotarget; 2017 May; 8(22):35984-36000. PubMed ID: 28415593
[TBL] [Abstract][Full Text] [Related]
9. The reduced PDCD5 protein is correlated with the degree of tumor differentiation in endometrioid endometrial carcinoma.
Gao M; Gao W; Wang Z; Liu Y; Li Y; Wei C; Sun Y; Guo C; Zhang L; Wei Z; Wang X
Springerplus; 2016; 5(1):988. PubMed ID: 27398268
[TBL] [Abstract][Full Text] [Related]
10. The p53 binding protein PDCD5 is not rate-limiting in DNA damage induced cell death.
Bock FJ; Tanzer MC; Haschka MD; Krumschnabel G; Sohm B; Goetsch K; Kofler R; Villunger A
Sci Rep; 2015 Jun; 5():11268. PubMed ID: 26062895
[TBL] [Abstract][Full Text] [Related]
11. Low programmed cell death 5 expression is a prognostic factor in ovarian cancer.
Gao L; Ye X; Ma RQ; Cheng HY; Han HJ; Cui H; Wei LH; Chang XH
Chin Med J (Engl); 2015 Apr; 128(8):1084-90. PubMed ID: 25881604
[TBL] [Abstract][Full Text] [Related]
12. PDCD5 transfection increases cisplatin sensitivity and decreases invasion in hepatic cancer cells.
Fan GL; Yao Y; Yao L; Li Y
Oncol Lett; 2015 Jan; 9(1):411-417. PubMed ID: 25436001
[TBL] [Abstract][Full Text] [Related]
13. The clinical value of the quantitative detection of four cancer-testis antigen genes in multiple myeloma.
Zhang Y; Bao L; Lu J; Liu KY; Li JL; Qin YZ; Chen H; Li LD; Kong Y; Shi HX; Lai YY; Liu YR; Jiang B; Chen SS; Huang XJ; Ruan GR
Mol Cancer; 2014 Feb; 13():25. PubMed ID: 24499297
[TBL] [Abstract][Full Text] [Related]
14. The involvement of programmed cell death 5 (PDCD5) in the regulation of apoptosis in cerebral ischemia/reperfusion injury.
Chen CH; Jiang Z; Yan JH; Yang L; Wang K; Chen YY; Han JY; Zhang JH; Zhou CM
CNS Neurosci Ther; 2013 Aug; 19(8):566-76. PubMed ID: 23638963
[TBL] [Abstract][Full Text] [Related]
15. Determination of PDCD5 in Peripheral Blood Serum of Cancer Patients.
Wang Y; Wang GH; Zhang QY
Chin J Cancer Res; 2011 Sep; 23(3):224-8. PubMed ID: 23467771
[TBL] [Abstract][Full Text] [Related]
16. PDCD5-regulated cell fate decision after ultraviolet-irradiation-induced DNA damage.
Zhuge C; Chang Y; Li Y; Chen Y; Lei J
Biophys J; 2011 Dec; 101(11):2582-91. PubMed ID: 22261045
[TBL] [Abstract][Full Text] [Related]
17. The role of heterogeneous nuclear ribonucleoprotein K in the progression of chronic myeloid leukemia.
Du Q; Wang L; Zhu H; Zhang S; Xu L; Zheng W; Liu X
Med Oncol; 2010 Sep; 27(3):673-9. PubMed ID: 19653139
[TBL] [Abstract][Full Text] [Related]
18. PDCD5 interacts with Tip60 and functions as a cooperator in acetyltransferase activity and DNA damage-induced apoptosis.
Xu L; Chen Y; Song Q; Xu D; Wang Y; Ma D
Neoplasia; 2009 Apr; 11(4):345-54. PubMed ID: 19308289
[TBL] [Abstract][Full Text] [Related]
19. Abnormal expression of the programmed cell death 5 gene in acute and chronic myeloid leukemia.
Ruan GR; Qin YZ; Chen SS; Li JL; Ma X; Chang Y; Wang YZ; Fu JY; Liu YR
Leuk Res; 2006 Sep; 30(9):1159-65. PubMed ID: 16507320
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
